Bone Biologics Corp (NASDAQ: BBLG)
$1.0000
+0.0181 ( -0.99% ) 58.8K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.0000
Previous close
$0.9819
Volume
58.8K
Market cap
$2.57M
Day range
$0.9980 - $1.0750
52 week range
$0.8000 - $6.0000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Dec 13, 2024 |
10-q | Quarterly Reports | 57 | Nov 14, 2024 |
8-k | 8K-related | 16 | Oct 21, 2024 |
4 | Insider transactions | 1 | Oct 18, 2024 |
3 | Insider transactions | 1 | Oct 18, 2024 |
8-k | 8K-related | 14 | Oct 04, 2024 |
8-k | 8K-related | 18 | Sep 27, 2024 |
8-k | 8K-related | 14 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |